Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by overthelakeonlyon Jul 29, 2016 9:39am

165 Views

Post# 25095082

TRIAL RESULTS

Spectral told that results should be released before the end of september because the enrolment was supposed to finish at the end of june but enrolment was finished around june,15. So results should be anytime in september.-----------------------------------------------------------------Then we can have only 5 to 6 weeks to wait for the results. ( VERY GOOD I HOPE )

Bullboard Posts

Corus reports Q1 profit drop in the face of falling revenue